当前位置：
X-MOL 学术
›
Pediatr. Allergy Immunol. Pulmonol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Could Age and Oral Challenge Outcomes Identify High-Risk Patients During Cow's Milk Oral Immunotherapy?
Pediatric Allergy, Immunology, and Pulmonology ( IF 1.1 ) Pub Date : 2022-06-16 , DOI: 10.1089/ped.2022.0003 Handan Duman Senol 1 , Ezgi Topyildiz 1 , Ezgi Ulusoy Severcan 2 , Sanem Eren Akercan 3 , Nursen Cigerci Gunaydin 4 , Figen Gulen 1 , Esen Demir 1
Pediatric Allergy, Immunology, and Pulmonology ( IF 1.1 ) Pub Date : 2022-06-16 , DOI: 10.1089/ped.2022.0003 Handan Duman Senol 1 , Ezgi Topyildiz 1 , Ezgi Ulusoy Severcan 2 , Sanem Eren Akercan 3 , Nursen Cigerci Gunaydin 4 , Figen Gulen 1 , Esen Demir 1
Affiliation
Objective: Severe immunglobuline E (IgE)-mediated reactions during oral immunotherapy (OIT) are major obstacles to treatment. The present study aimed to evaluate and identify clinical and laboratory biomarkers of adverse events during OIT among children with cow's milk (CM) allergy.
中文翻译：
年龄和口腔挑战结果能否识别牛奶口服免疫治疗期间的高危患者？
目的：口服免疫治疗 (OIT) 期间严重的免疫球蛋白 E (IgE) 介导的反应是治疗的主要障碍。本研究旨在评估和确定牛奶 (CM) 过敏儿童 OIT 期间不良事件的临床和实验室生物标志物。
更新日期：2022-06-20
中文翻译：
年龄和口腔挑战结果能否识别牛奶口服免疫治疗期间的高危患者？
目的：口服免疫治疗 (OIT) 期间严重的免疫球蛋白 E (IgE) 介导的反应是治疗的主要障碍。本研究旨在评估和确定牛奶 (CM) 过敏儿童 OIT 期间不良事件的临床和实验室生物标志物。
京公网安备 11010802027423号